The Biotech Investor's Bible

George Wolff
John Wiley and Sons
Publication date: 


ISBN 0471412791
This book explains the business side of biotechnology to investors, and contains a very good assessment of individual biotechnology companies. Specifically, it ranks biotech companies into "tiers" according to their maturity and potential, with "Tier 1" being the very few biotech companies that are actually breaking even. It's good to get a feel for the way that investors view the industry. The disadvantage of this or any other book of its type, of course, is that it is likely to go out of date very fast.


Reviewed by: 
Jim DeKloe


  • Learn about biotech careers
  • Find biotech programs

Learn more »


  • Professional development
  • View curriculum

Learn more »


  • Connect with local programs
  • Find skilled workers

Learn more »